DE1695100A1 - Verfahren zur Herstellung von neuen substituierten Aminen - Google Patents
Verfahren zur Herstellung von neuen substituierten AminenInfo
- Publication number
- DE1695100A1 DE1695100A1 DE19661695100 DE1695100A DE1695100A1 DE 1695100 A1 DE1695100 A1 DE 1695100A1 DE 19661695100 DE19661695100 DE 19661695100 DE 1695100 A DE1695100 A DE 1695100A DE 1695100 A1 DE1695100 A1 DE 1695100A1
- Authority
- DE
- Germany
- Prior art keywords
- hydrogen
- alkyl group
- formula
- group
- theophylline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001412 amines Chemical class 0.000 title description 3
- 238000000034 method Methods 0.000 title description 3
- 238000002360 preparation method Methods 0.000 title description 3
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 claims description 18
- 125000000217 alkyl group Chemical group 0.000 claims description 16
- 150000001875 compounds Chemical class 0.000 claims description 13
- 229910052739 hydrogen Inorganic materials 0.000 claims description 13
- 239000001257 hydrogen Substances 0.000 claims description 13
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 11
- 229960000278 theophylline Drugs 0.000 claims description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
- 229960004767 proxyphylline Drugs 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 229960004559 theobromine Drugs 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 claims description 2
- KYHQZNGJUGFTGR-UHFFFAOYSA-N Proxyphylline Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2CC(O)C KYHQZNGJUGFTGR-UHFFFAOYSA-N 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- -1 chlorohydroxypropyl theophylline Chemical compound 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 2
- XTLNYNMNUCLWEZ-UHFFFAOYSA-N ethanol;propan-2-one Chemical compound CCO.CC(C)=O XTLNYNMNUCLWEZ-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- DLNKOYKMWOXYQA-APPZFPTMSA-N phenylpropanolamine Chemical compound C[C@@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-APPZFPTMSA-N 0.000 description 2
- 229960000395 phenylpropanolamine Drugs 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- DLNKOYKMWOXYQA-CBAPKCEASA-N (-)-norephedrine Chemical compound C[C@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-CBAPKCEASA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010062119 Sympathomimetic effect Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000001975 sympathomimetic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT1111865A AT269171B (de) | 1965-12-10 | 1965-12-10 | Verfahren zur Herstellung von neuen substituierten Aminen und deren Salzen |
| AT272766A AT270673B (de) | 1966-03-22 | 1966-03-22 | Verfahren zur Herstellung von neuen substituierten Aminen oder deren Salzen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1695100A1 true DE1695100A1 (de) | 1970-12-10 |
Family
ID=25598985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19661695100 Pending DE1695100A1 (de) | 1965-12-10 | 1966-11-30 | Verfahren zur Herstellung von neuen substituierten Aminen |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JPS5113160B1 (enrdf_load_stackoverflow) |
| BE (1) | BE690863A (enrdf_load_stackoverflow) |
| CH (2) | CH496013A (enrdf_load_stackoverflow) |
| DE (1) | DE1695100A1 (enrdf_load_stackoverflow) |
| ES (1) | ES334064A1 (enrdf_load_stackoverflow) |
| FR (2) | FR1504939A (enrdf_load_stackoverflow) |
| GB (1) | GB1156719A (enrdf_load_stackoverflow) |
| SE (1) | SE345669B (enrdf_load_stackoverflow) |
-
1966
- 1966-11-30 DE DE19661695100 patent/DE1695100A1/de active Pending
- 1966-12-02 ES ES0334064A patent/ES334064A1/es not_active Expired
- 1966-12-08 CH CH1755266A patent/CH496013A/de not_active IP Right Cessation
- 1966-12-08 SE SE16834/66A patent/SE345669B/xx unknown
- 1966-12-08 CH CH991470A patent/CH496014A/de not_active IP Right Cessation
- 1966-12-08 JP JP41080097A patent/JPS5113160B1/ja active Pending
- 1966-12-08 BE BE690863D patent/BE690863A/xx unknown
- 1966-12-09 GB GB55188/66A patent/GB1156719A/en not_active Expired
- 1966-12-09 FR FR86792A patent/FR1504939A/fr not_active Expired
-
1967
- 1967-03-09 FR FR98053A patent/FR7018M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ES334064A1 (es) | 1967-10-16 |
| CH496014A (de) | 1970-09-15 |
| JPS5113160B1 (enrdf_load_stackoverflow) | 1976-04-26 |
| FR1504939A (fr) | 1967-12-08 |
| CH496013A (de) | 1970-09-15 |
| GB1156719A (en) | 1969-07-02 |
| BE690863A (enrdf_load_stackoverflow) | 1967-06-08 |
| SE345669B (enrdf_load_stackoverflow) | 1972-06-05 |
| FR7018M (enrdf_load_stackoverflow) | 1969-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2139526A1 (enrdf_load_stackoverflow) | ||
| DE2165056C3 (de) | Verfahren zur Herstellung von CMnazollnonen | |
| EP0047328A1 (de) | 1H- und 2H-Indazolderivate und diese enthaltendes Arzneimittel | |
| DE2603046C2 (de) | 4'α- und 4'β-Amino-4'-desoxy-oleandrine, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate | |
| DE1695100A1 (de) | Verfahren zur Herstellung von neuen substituierten Aminen | |
| DE1595894A1 (de) | Neue 1,5-Diazabicyclo[3,3,0]octan-2,6-dione | |
| DE1620381A1 (de) | Derivate des 2-Aminopyrazins und Verfahren zu ihrer Herstellung | |
| EP0001760B1 (de) | Alpha-aminomethylen-beta-formylaminopropionitril, Verfahren zu seiner Herstellung sowie Verwendung zur Herstellung von 2-Methyl-4-amino-5-formylaminomethyl-pyrimidin | |
| DE1670478A1 (de) | Verfahren zur Herstellung von Derivaten des alpha-Piperazino-phenylacetonitrils | |
| DE2303176A1 (de) | Substituierte 5-chromanole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate | |
| DE1795635C3 (de) | 2,4-Diamino-5-benzyIpyrimidine | |
| AT270673B (de) | Verfahren zur Herstellung von neuen substituierten Aminen oder deren Salzen | |
| US3828048A (en) | Alkylsulfonic derivatives of quinine alkaloids | |
| DE1962261C3 (de) | Verfahren zur Herstellung von 2,6- Bis-(diäthanolamino)-4,8-dipiperidinopyrimido[5,4-d]pyrimidin | |
| DE2008875A1 (de) | Pyrimidinderivate | |
| DE1470102A1 (de) | 2-Hydroxymethyl-5-nitroimidazole und Verfahren zu deren Herstellung | |
| DE1242603B (de) | Verfahren zur Herstellung von 5-Hydroxy-5-aminoalkyl-di-benzo-[a, d]-cycloheptanen | |
| DE2457666A1 (de) | Arzneimittel, verfahren zur herstellung von dafuer geeigneten wirkstoffen und diese oxoalkyl-dialkyl-xanthine | |
| DE3018514A1 (de) | 6,7-secoergoline | |
| AT251585B (de) | Verfahren zur Herstellung von neuen 6,7-Dihydro-5H-pyrrolo-[3,4-d]-pyrimidinen | |
| DE1770183A1 (de) | Neue tertiaere Estersalze und Verfahren zur Herstellung derselben | |
| DE2003840A1 (de) | 3-Phenyl-4-acyloxycarbostyrile,Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln | |
| DE2149740A1 (de) | Neues Verfahren zur Herstellung von substituierten Cobamiden | |
| AT313889B (de) | Verfahren zur Herstellung von neuen 2-(Furyl-methyl)-6,7-benzomorphanderivaten und deren Säureadditionssalzen | |
| DE2241566C3 (de) | 1-geschweifte Klammer auf 1-eckige Klammer auf 3-(p-Fluorphenylthio)-1-propenyl eckige Klammer zu-4-piperidyl geschweifte Klammer zu-2-oxo-benzimidazolin |